Cite
HARVARD Citation
Moore, S. et al. (n.d.). Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma. European journal of haematology. pp. 420-425. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moore, S. et al. (n.d.). Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma. European journal of haematology. pp. 420-425. [Online].